BPI-9016M, a c-Met inhibitor, suppresses tumor cell growth, migration and invasion of lung adenocarcinoma via miR203-DKK1Panpan Zhang(Sun Yat-sen University), Yue Yang(Peking University Cancer Hospital)TheranosticsJanuary 1, 201810.7150/thno.27667Cited by 56SaveCiteExport RISWatch citationsRelated PapersUpregulation of programmed cell death ligand 1 promotes resistance response in non‐small‐cell lung cancer patients treated with neo‐adjuvant chemotherapy|Cancer Science|2016|184Efficacy and safety of HBM4003 combined with toripalimab in refractory neuroendocrine neoplasms: a multicenter, phase II study|EClinicalMedicine|2025|3